+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cholera Vaccines Market - Global Forecast 2026-2032- Product Image
Cholera Vaccines Market - Global Forecast 2026-2032- Product Image
New

Cholera Vaccines Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5968086
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cholera vaccines market continues to evolve rapidly, shaped by innovations in vaccine science, advances in delivery models, and the changing needs of global health systems. As stakeholders tackle persistent challenges in disease control and equitable access, a clear understanding of these trends is fundamental for strategic decision-making.

Market Snapshot: Cholera Vaccines Market Growth

The Cholera Vaccines Market grew from USD 329.81 million in 2025 to USD 353.18 million in 2026. It is anticipated to expand at a CAGR of 7.56%, reaching USD 549.59 million by 2032. This robust progression is fueled by international commitments to epidemic preparedness, enhanced formulation science, and the imperative to secure vaccine access for vulnerable populations amid evolving outbreak risks.

Scope & Segmentation

This report delivers comprehensive segmentation insights on products, delivery models, and market end-users, empowering targeted strategy:

  • Vaccine Types: Injectable and oral cholera vaccines, each optimized for different deployment scenarios and immunization outcomes.
  • Dosage Forms: Includes liquid and lyophilized presentations, differentiated by shelf life, cold chain needs, and administration approaches.
  • Presentation Formats: Multi-dose and single-dose vials, supporting either mass campaigns or targeted, lower-wastage distribution models.
  • Distribution Channels: Hospital pharmacies, retail pharmacies, online distribution, each catering to specific routine, travel, or emergency immunization requirements.
  • End-User Segments: Ambulatory centers, clinics, hospitals, and research facilities, with tailored clinical and logistical needs.
  • Age Group Priorities: Vaccination plans for adult, geriatric, and pediatric populations, each with distinct safety and acceptance considerations.
  • Intended Application: Prophylactic versus therapeutic uses, affecting regulatory criteria and surveillance requirements.
  • Geographical Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, each with unique manufacturing, regulatory, and deployment structures shaping program design.

Key Takeaways for Senior Decision-Makers

  • Advances in thermostable and single-dose solutions are expanding vaccine reach into regions with limited cold chain capacity and urgent outbreak contexts.
  • Collaborations among public agencies and private sector players continue to accelerate technology transfer and fast-track manufacturing localization, improving supply security.
  • Segmented delivery and packaging solutions allow organizational flexibility, reducing wastage and customizing approaches for various healthcare environments.
  • Data-driven surveillance and cold chain monitoring are now integral, as stakeholders leverage digital tools for improved coverage and safety tracking.
  • Shifting regulatory landscapes and harmonized procurement requirements are trimming approval timelines and promoting broader access.
  • Regional variations require tailored product attributes and distribution models, reflecting local health infrastructure and epidemiological trends.

Impact of Tariff Policies on Supply Chains

Recent tariff measures on medical supplies, including vaccine components and equipment, impose cost pressures that manufacturers and procurement leaders cannot ignore. Elevated supply chain risks lead organizations to reassess supplier portfolios and favor regional manufacturing or alternate sourcing. Longer lead times and inventory complexities necessitate conservative procurement tactics and the renegotiation of supply contracts to ensure continuity. Policy responses from governments and donors frequently involve tariff exemptions or support for local production, and contingency planning becomes critical for operational resilience. Strategic diversification, fill-finish partnerships, and pooled procurement are increasingly vital to diffuse tariff impacts across program stakeholders.

Cholera Vaccines Market: Methodology & Data Sources

This market assessment combines a systematic literature review with interviews from vaccine developers, manufacturers, public health experts, and procurement professionals. Secondary sources span scientific journals, technical guidelines, and national program documents. Triangulation and expert panel review underpin finding validity, while scenario analysis of supply disruptions and policy shifts informs actionable recommendations.

Why This Report Matters

  • Equips leaders with validated, segmented insights to inform investment, procurement, and operational strategy in the cholera vaccines space.
  • Delivers a holistic view of disruptive innovation, manufacturing trends, and regulatory changes underpinning new opportunities and challenges.
  • Supports program planning with evidence-based perspectives on technology adoption, regional customization, and risk mitigation.

Conclusion

As cholera vaccination strategies adapt to scientific advances and operational realities, decision-makers benefit from prioritized, segmented, and actionable intelligence. Collaboration, supply agility, and regulatory responsiveness will remain central to safeguarding public health through optimized vaccine delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cholera Vaccines Market, by Vaccine Type
8.1. Injectable Vaccine
8.2. Oral Vaccine
9. Cholera Vaccines Market, by Route Of Administration
9.1. Intramuscular
9.2. Oral
10. Cholera Vaccines Market, by Dosage Form
10.1. Liquid
10.2. Lyophilized
11. Cholera Vaccines Market, by Presentation Type
11.1. Multi Dose
11.2. Single Dose
12. Cholera Vaccines Market, by Age Group
12.1. Adult
12.2. Geriatric
12.3. Pediatric
13. Cholera Vaccines Market, by Application
13.1. Prophylactic
13.2. Therapeutic
14. Cholera Vaccines Market, by End User
14.1. Ambulatory Centers
14.2. Clinics
14.3. Hospitals
14.4. Research Facilities
15. Cholera Vaccines Market, by Distribution Channel
15.1. Hospital Pharmacy
15.2. Online Pharmacy
15.3. Retail Pharmacy
16. Cholera Vaccines Market, by Region
16.1. Americas
16.1.1. North America
16.1.2. Latin America
16.2. Europe, Middle East & Africa
16.2.1. Europe
16.2.2. Middle East
16.2.3. Africa
16.3. Asia-Pacific
17. Cholera Vaccines Market, by Group
17.1. ASEAN
17.2. GCC
17.3. European Union
17.4. BRICS
17.5. G7
17.6. NATO
18. Cholera Vaccines Market, by Country
18.1. United States
18.2. Canada
18.3. Mexico
18.4. Brazil
18.5. United Kingdom
18.6. Germany
18.7. France
18.8. Russia
18.9. Italy
18.10. Spain
18.11. China
18.12. India
18.13. Japan
18.14. Australia
18.15. South Korea
19. United States Cholera Vaccines Market
20. China Cholera Vaccines Market
21. Competitive Landscape
21.1. Market Concentration Analysis, 2025
21.1.1. Concentration Ratio (CR)
21.1.2. Herfindahl Hirschman Index (HHI)
21.2. Recent Developments & Impact Analysis, 2025
21.3. Product Portfolio Analysis, 2025
21.4. Benchmarking Analysis, 2025
21.5. AstraZeneca PLC
21.6. Bavarian Nordic A/S
21.7. Bharat Biotech International Limited
21.8. Emergent BioSolutions Inc.
21.9. EuBiologics Co. Ltd.
21.10. GlaxoSmithKline PLC
21.11. Johnson & Johnson
21.12. Merck & Co. Inc.
21.13. Mitsubishi Tanabe Pharma Corporation
21.14. Novartis AG
21.15. PaxVax Inc.
21.16. Pfizer Inc.
21.17. Sanofi Pasteur SA
21.18. Serum Institute of India Pvt. Ltd.
21.19. Shantha Biotechnics Limited
21.20. Takeda Pharmaceutical Company Limited
21.21. Valneva SE
List of Figures
FIGURE 1. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CHOLERA VACCINES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CHOLERA VACCINES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 15. UNITED STATES CHOLERA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 16. CHINA CHOLERA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INJECTABLE VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INJECTABLE VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INJECTABLE VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LYOPHILIZED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LYOPHILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CHOLERA VACCINES MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CHOLERA VACCINES MARKET SIZE, BY MULTI DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CHOLERA VACCINES MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CHOLERA VACCINES MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CHOLERA VACCINES MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CHOLERA VACCINES MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PROPHYLACTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PROPHYLACTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CHOLERA VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CHOLERA VACCINES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CHOLERA VACCINES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CHOLERA VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CHOLERA VACCINES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CHOLERA VACCINES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CHOLERA VACCINES MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CHOLERA VACCINES MARKET SIZE, BY RESEARCH FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CHOLERA VACCINES MARKET SIZE, BY RESEARCH FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CHOLERA VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CHOLERA VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CHOLERA VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS CHOLERA VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. EUROPE CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. EUROPE CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 110. EUROPE CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 111. EUROPE CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 113. EUROPE CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. EUROPE CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. EUROPE CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. AFRICA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 127. AFRICA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 128. AFRICA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 129. AFRICA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 130. AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 131. AFRICA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. AFRICA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. ASEAN CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. ASEAN CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 146. ASEAN CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 147. ASEAN CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 148. ASEAN CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 149. ASEAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 150. ASEAN CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. ASEAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. ASEAN CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 153. GCC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GCC CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 155. GCC CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 156. GCC CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 157. GCC CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 158. GCC CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 159. GCC CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. GCC CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. GCC CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. BRICS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. BRICS CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 173. BRICS CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 174. BRICS CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 175. BRICS CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 176. BRICS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 177. BRICS CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. BRICS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. BRICS CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. G7 CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. G7 CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 182. G7 CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 183. G7 CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 184. G7 CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 185. G7 CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 186. G7 CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. G7 CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. G7 CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. NATO CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. NATO CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 191. NATO CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 192. NATO CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 193. NATO CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 194. NATO CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 195. NATO CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. NATO CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. NATO CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. UNITED STATES CHOLERA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 200. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 201. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 202. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 203. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 204. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 205. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. CHINA CHOLERA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. CHINA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 210. CHINA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 211. CHINA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 212. CHINA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2032 (USD MILLION)
TABLE 213. CHINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 214. CHINA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. CHINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. CHINA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cholera Vaccines market report include:
  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bharat Biotech International Limited
  • Emergent BioSolutions Inc.
  • EuBiologics Co. Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Novartis AG
  • PaxVax Inc.
  • Pfizer Inc.
  • Sanofi Pasteur SA
  • Serum Institute of India Pvt. Ltd.
  • Shantha Biotechnics Limited
  • Takeda Pharmaceutical Company Limited
  • Valneva SE

Table Information

Report AttributeDetails
No. of Pages185
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 353.18 Million
Forecasted Market Value ( USD ) by 2032 $ 549.59 Million
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Cholera Vaccines - Global Strategic Business Report - Product Image

Cholera Vaccines - Global Strategic Business Report

  • Report
  • 367 Pages
  • Global
From
Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Cholera Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Cholera Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Cholera Vaccines Market Report by Vaccine Type, Product, End User, and Region 2025-2033 - Product Image

Cholera Vaccines Market Report by Vaccine Type, Product, End User, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Hog Cholera Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Hog Cholera Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Cholera Vaccine Market

The Cholera Vaccine market is a subset of the larger Vaccines market. Cholera is an acute diarrheal infection caused by the bacterium Vibrio cholerae. Vaccines are the most effective way to prevent cholera, and the World Health Organization recommends that all people at risk of cholera should be vaccinated. The Cholera Vaccine market is composed of a variety of products, including oral and injectable vaccines. Oral vaccines are typically administered in two doses, while injectable vaccines are administered in a single dose. The Cholera Vaccine market is highly competitive, with a number of companies offering products. These include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Emergent BioSolutions. Each company offers a range of products, including both oral and injectable vaccines. Additionally, some companies have developed combination vaccines that protect against multiple diseases, including cholera. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.